RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81

Ads

You May Also Like

Cyclacel Pharmaceuticals Reports 3rd Quarter 2016 Financial Results

BERKELEY HEIGHTS, N.J., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ...

Biocartis Group NV: BIOCARTIS KONDIGT H1 2018 RESULTATEN AAN

  PERSBERICHT: GEREGLEMENTEERDE INFORMATIE Donderdag, 6 september 2018, 07:00 CEST BIOCARTIS KONDIGT H1 2018 RESULTATEN ...